News and Press Releases - Geron Corporation

September is Blood Cancer Awareness Month. We stand with everyone living with blood cancer — this month and every day.

The latest from Geron.

Company news, financial updates, scientific presentations, and events as we advance treatments for people living with blood cancer.

Press releases

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 18, 2026

Geron Corporation Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Geron Plans to Announce Second Quarter 2026 Financial Results on August 5, 2026

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Geron Announces Appointment of Chinmaya Rath as Chief Business Officer

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026

Geron Corporation Reports First Quarter 2026 Financial Results and Recent Business Highlights

Geron Plans to Present at Upcoming Investor Conferences

view all of Geron’s past releases

Events

geron event post image - Q2 2026 Geron Earnings Conference Call

Q2 2026 Geron Earnings Conference Call

47th annual global healthcare conference title slide

Goldman Sachs 47th Annual Global Healthcare Conference